Credit Suisse’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.83M | Buy |
|
|||||
|
2023
Q4 | $3.17M | Sell |
|
|||||
|
2023
Q3 | $1.57M | Buy |
|
|||||
|
2023
Q2 | $4.52M | Buy |
|
|||||
|
2023
Q1 | $2.21M | Buy |
|
|||||
|
2022
Q4 | $1.63M | Buy |
|
|||||
|
2022
Q3 | $812K | Buy |
|
|||||
|
2022
Q2 | $520K | Sell |
|
|||||
|
2022
Q1 | $1.21M | Buy |
|
|||||
|
2021
Q4 | $2.3M | Buy |
|
|||||
|
2021
Q3 | $3.96M | Buy |
|
|||||
|
2021
Q2 | $4.57M | Sell |
|
|||||
|
2021
Q1 | $18.4M | Buy |
|
|||||
|
2020
Q4 | $10M | Buy |
|
|||||
|
2020
Q3 | $4.37M | Sell |
|
|||||
|
2020
Q2 | $7.04M | Buy |
|
|||||
|
2020
Q1 | $1.26M | Sell |
|
|||||
|
2019
Q4 | $1.78M | Buy |
|
|||||
|
2019
Q3 | $430K | Buy |
|
|||||
|
2019
Q2 | $428K | Sell |
|
|||||
|
2019
Q1 | $482K | Buy |
|
|||||
|
2018
Q4 | $202K | Buy |
|
|||||
|
2018
Q3 | $242K | Sell |
|
|||||
|
2018
Q2 | $741K | Sell |
|
|||||
|
2018
Q1 | $1.13M | Buy |
|
|||||
|
2017
Q4 | $548K | Sell |
|
|||||
|
2017
Q3 | $2.66M | Buy |
|
|||||
|
2017
Q2 | $2.02M | Buy |
|
|||||
|
2017
Q1 | $1.68M | Buy |
|
|||||
|
2016
Q4 | $250K | Sell |
|
|||||
|
2016
Q3 | $586K | Sell |
|
|||||
|
2016
Q2 | $1.17M | Buy |
|
|||||
|
2016
Q1 | $340K | Buy |
|
|||||
|
2015
Q4 | $420K | Buy |
|
|||||
|
2015
Q3 | $209K | Sell |
|
|||||
|
2015
Q2 | $1.35M | Buy |
|
|||||
|
2015
Q1 | $401K | Sell |
|
|||||
|
2014
Q4 | $713K | Buy |
|
|||||
|
2014
Q3 | $264K | Sell |
|
|||||
|
2014
Q2 | $362K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $42K | Buy |
|